Vimarsana
Biggest News Aggregation in the World

Jamie Rossjohn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamie Rossjohn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamie Rossjohn Today - Breaking & Trending Today

Immutep Quarterly Activities Report Q2 FY24 - Vimarsana News

Immutep Quarterly Activities Report Q2 FY24

Media Release Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer patients expressing PD-L1...

Gadeta Appoints Scientific Advisory Board and Provides Business Update - Vimarsana News

Gadeta Appoints Scientific Advisory Board and Provides Business Update

Distinguished leaders in immunology and translational oncology join to support the Company's scientific approachStrengthening the focus on solid tumors and progressing two programs towards the

Outstanding Academy Fellows elected to Royal Society | Australian Academy of Science - Vimarsana News

Outstanding Academy Fellows elected to Royal Society | Australian Academy of Science

From (L-R): Professors Carola Vinuesa FAA FRS FAHMS, Bob Pressey FAA FRS, Richard Robson FAA FRS and Jamie Rossjohn FAA FRS FAHMS. Photos: supplied Four Australian scientists have been elected Fellows of the Royal Society, the world’s oldest scientific academy in continuous existence, for their outstanding contributions to scientific understanding.

Enara Bio and Collaborators Present Progress Towards Developing MR1-targeted T-Cell Therapies at 12th International CD1-MR1 EMBO Meeting - Vimarsana News

Enara Bio and Collaborators Present Progress Towards Developing MR1-targeted T-Cell Therapies at 12th International CD1-MR1 EMBO Meeting

OXFORD, England, May 9, 2022 /PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific

SARS-CoV-2 vaccination creates a strong, persistent T-cell response - Vimarsana News

SARS-CoV-2 vaccination creates a strong, persistent T-cell response

/PRNewswire/ -- Scientists have harnessed T cells to better understand the immune response to mRNA vaccines against SARS-CoV-2, the virus that causes COVID-19....